Skip to content

Psychopathology and Cognition in 22q11 CNV disorders

Psychopathology and Cognition in 22q11 CNV disorders - 22q11 CNV disorders

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON47626
Enrollment
100
Registered
2014-12-24
Start date
2015-03-24
Completion date
Unknown
Last updated
2024-06-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

22q111 CNV disorders disorders of chromosome 22

Interventions

None listed

Sponsors

Medisch Universitair Ziekenhuis Maastricht
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: In order to be eligible to participate in this study, a subject must meet all of the following criteria: -A deletion or duplication at chromosome 22q11 confirmed by FISH, micro-array or MLPA analysis. -ability to give informed consent -Written informed consent by participant -Age 18 -65 years

Exclusion criteria

Exclusion criteria: A potential subject who meets any of the following criteria will be excluded from participation in this study: -chromosomal abnormalities other than 22q11 CNVs

Design outcomes

Primary

MeasureTime frame
Neuropsychological outcome measures (working memory, attention, social cognition,verbal memory, processing speed, visual memory, planning), a cognitive composite score bases on the total score of the CANTAB subtests (representing cognitive function), IQ, psychiatric diagnosis

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)